CN1202374A - Chinese herbal medicine wine for curing leukamia - Google Patents
Chinese herbal medicine wine for curing leukamia Download PDFInfo
- Publication number
- CN1202374A CN1202374A CN 98113258 CN98113258A CN1202374A CN 1202374 A CN1202374 A CN 1202374A CN 98113258 CN98113258 CN 98113258 CN 98113258 A CN98113258 A CN 98113258A CN 1202374 A CN1202374 A CN 1202374A
- Authority
- CN
- China
- Prior art keywords
- radix
- wine
- medicament
- caulis
- treatment according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese herbal medicine wine is compounded with saffron, Setose thistle, ginseng, reticulate millettia, red sage and other 15 kinds of Chinese medicinal materials in certain proportion and white spirits. The unique formula of the present invention results in obvious cure effect.
Description
The present invention relates to the leukemic medicated wine of a kind of treatment.Be to be the medicated wine of feedstock production with the Chinese herbal medicine specifically.
Leukemia is the disease of serious harm human health, is malignant tumor of hematopoiesis system.Leukemia generally is divided into three kinds: the acute leukemia outbreak is very fast, and the patient usually enters blood because of the leukaemia, soaks into lymph node, spleen and other important organ and death; The clinical normal appearance of chronic lymphocytic leukemia and chronic myelocytic leukemia patient: tired, become thin, symptom such as low grade fever, anemia or hemorrhage, lymph node regulating liver-QI spleen enlargement, though can survive for many years, prognosis is not good.
At present, both at home and abroad to the primary disease Drug therapy,, often adopt the embolic chemotherapy treatment for acute leukemic patient.But, to be killed at the chemotherapeutic period sensitive cells, mdr cell is then by the selectivity raised growth.The leukaemia develops immunity to drugs to chemotherapeutics becomes the one of the main reasons of leukemia chemotherapy failure.For chronic myelocytic leukemia patient's Drug therapy, often adopt medicines such as hydroxyurea, Busulfan, but adopt the hydroxyurea treatment, its defective be curative effect permanent, need keep treatment, and expense is higher; Can occur the Busulfan life-time service pigmentation, body weight reduce and tired, the class radiation function arranged.For the Drug therapy of chronic lymphocytic leukemia, chlorambucil wherein can cause gastrointestinal reaction and bone marrow depression, the ring squama amide cystitis that can cause bleeding, and fluorine is rattled away to even up and can be caused bone marrow depression, vomiting and nervus centralis toxicity.In addition, interferon and bone marrow transplantation therapy are also adopted in leukemic treatment, usually make most of patient's abandoning cure at home because of expense is expensive.
The object of the present invention is to provide a kind ofly to have the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling, removing heat from blood and separate blood poison and antibacterial functions, and the patient is not had the toxic and side effects of generation and the cheap leukemic herbal wine of treatment of expense.
The composition proposal of medicament of the present invention is based on Chinese medical science to leukemic pathogenetic long-term understanding and Therapeutic Principle, according to the leukemic proved recipe of treatment handed down from one's ancestors among the people, with reference to modern pharmacological research achievement, therefrom optimize the medicine that the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling, removing heat from blood are separated blood poison antibacterial functions.
Medicament of the present invention is to be made by the raw material of following weight proportioning: safflower 20~40 setose thistles 130~160 Niu Dali 130~170 ginsengs 140~160 reticulate millettias 140~160 reds sage root 280~320 are strangled disconnected 140~160 radix paeoniae rubrathe, 130~160 ilex pubescens, 130~170 radix scrophulariae, 240~260 caulis loniceraes, 230~270 sarcandras, 140~160 Sculellaria barbatas, 140~160 curcuma zedoarys, 140~160 caulis trachelospermis, 140~160 mountains on the other way round, 240~260 moutan barks, 140~160 giant knotweeds, 240~260 chinaroot greenbriers, 240~260 rivers 140~160 liquor 25000 that disappear in vain
The weight proportion for preparing the formula optimization of medicament of the present invention is: Stigma Croci 30 Radix Cirsii Japonicis 150 Millettia Speciosa 150 Radix Ginsengs 150 Caulis Spatholobis 150 Radix Salviae Miltiorrhizaes 300 are reined in 250 Cortex Moutans, 150 Rhizoma Polygoni Cuspidati, 250 Rhizoma Smilacis Chinensiss, 250 Radix Dipsaci, 150 Radix Paeoniae Rubra, 150 Radix Ilicis Pubescentiss, 150 Radix Scrophulariae, 250 Caulis Loniceraes, 250 Herba Pileae Scriptaes, 150 Herba Scutellariae Barbataes, 150 Rhizoma Curcumae, 150 Caulis Trachelospermis, 150 Radix cynanchi wilfordii, 150 Chinese liquor 25000 in vain
Above-mentioned said medicament is a said Chinese herbal medicine on any pharmaceutics, and the number of degrees of said Chinese liquor are between 50 to 55 degree.
Motherland's medical science is pointed out: human body is made up of various pipelines such as muscles and bones, internal organs, blood vessel, meridians, hole, cave, lymphatic vessel, sweat gland, respiratory tract, esophaguses.Unobstructed of pipeline reaches, and does not have viral pathogen to block, and the people is just healthy.On the contrary, various noxious substances hinder the pipeline QI-blood circulation, just are in onset state.Huangdi's Internal Classics is pointed out: " the passages through which vital energy circulates person, so the life and death of determining is located all kinds of diseases and ailments, correcting the deficiency and excess can not be obstructed." Chinese herbal medicine be Chinese nation's excellent traditional culture important composition partly, be the rarity of a brilliance.For thousands of years, China working people for a long time it as the primary armament of preventing and curing diseases.
According to the modern science certificate of analysis, contain elements such as cellulosic, multivitamin, aminoacid, calcium, iodine, sugar in the said herbal medicine, be the needed by human body material.The potassium that contains in the said herbal medicine, alkali etc. can be dissolved the acid matter blood of oncogenic virus in the body.
The many primary disease of human body because of the source, all by heat in blood blood poison and meridians obstruction and form.Dialectical according to this, be made into the Chinese herbal medicine medicated wine, to borrow wine inducting the medicines into affected channel network (wine has effects such as " promoting blood circulation, row medicine gesture, warming the spleen stomach, imperial wind and cold "), can impel heat in blood blood poison and blood circulation promoting and blood stasis dispelling in the quick removing body, strengthening vital QI to eliminate pathogenic factors is prevented and cured diseases.Huangdi's Internal Classics is pointed out: " promoting circulation of QI-blood make it reach, and it is flat to make peace." " interior warp " point out again: " vim and vigour discord, all kinds of diseases and ailments are to change and give birth to.”
In this medicated wine, select the medicine of many blood circulation promoting and blood stasis dispelling for use.Blood circulation promoting and blood stasis dispelling is a kind of unique therapy of motherland's medical science, in the treatment various diseases, many-sided therapeutical effect is arranged: impel vasodilation, blood flow increasing is accelerated the microcirculation velocity of blood flow, increases the blood capillary network; Regulate reactivity of organism, strengthen antibacterial toxin expelling; Impel proliferative lesion softening, suppress the leukemia growth of tumour cell, regulate functions such as human body metabolic disorder.In the above-mentioned medicament: Rhizoma Curcumae, Herba Pileae Scriptae, rein in vain, Rhizoma Smilacis Chinensis etc., all be cancer therapy drug.In the past few years, cooperate Chinese herbal medicine powder or water preparation to treat the leukemia that forms because of the blood poison clinically with this medicated wine, curative effect is fine, and cure rate reaches more than 85%.To Leukemia Patients there is not any toxic and side effects of generation.
The clinical treatment example:
Li Huiqing: the woman, 51 years old, the cotton north of the city in Chaoyang city closed road 503.Suffer from hepatocarcinoma, rectal cancer and cholelithiasis.Former through Shantou City central hospital have an operation and radiotherapy invalid, fully recover through taking this medicated wine and the medicine back of loosing.
Jiang Xiaofang: woman, 44 years old, the office worker of Chaoyang city grains bureau.Suffer from liver sausage cancer and renal calculus.Former invalid through Shantou central hospital radiotherapy, through take this medicated wine and medicine loose after rehabilitation.
Weng Genglin: man, 76 years old, back, Xia Shan town, Chaoyang city English.Suffer from hepatocarcinoma.Former invalid through Shantou central hospital radiotherapy, through take this medicated wine and medicine loose after rehabilitation.
Claims (5)
1, a kind ofly treat leukemic herbal wine, it is characterized in that it is the medicament of being made by the raw material of following weight proportioning: safflower 20~40 setose thistles 130~160 Niu Dali 130~170 ginsengs 140~160 reticulate millettias 140~160 reds sage root 280~320 are strangled disconnected 140~160 radix paeoniae rubrathe, 130~160 ilex pubescens, 130~170 radix scrophulariae, 240~260 caulis loniceraes, 230~270 sarcandras, 140~160 Sculellaria barbatas, 140~160 curcuma zedoarys, 140~160 caulis trachelospermis, 140~160 mountains on the other way round, 240~260 moutan barks, 140~160 giant knotweeds, 240~260 chinaroot greenbriers, 240~260 rivers 140~160 liquor 25000 that disappear in vain
2, the leukemic herbal wine of treatment according to claim 1, wherein the weight proportion of each raw material is:
Stigma Croci 30 Radix Cirsii Japonicis 150 Millettia Speciosa 150 Radix Ginsengs 150
Caulis Spatholobi 150 Radix Salviae Miltiorrhizaes 300 are reined in 250 Cortex Moutans 150 in vain
Rhizoma Polygoni Cuspidati 250 Rhizoma Smilacis Chinensiss 250 Radix Dipsaci 150 Radix Paeoniae Rubra 150
Radix Ilicis Pubescentis 150 Radix Scrophulariae 250 Caulis Loniceraes 250 Herba Pileae Scriptaes 150
Herba Scutellariae Barbatae 150 Rhizoma Curcumae 150 Caulis Trachelospermis 150 Radix cynanchi wilfordii 150
Chinese liquor 25000
3, the leukemic herbal wine of treatment according to claim 1 and 2 is characterized in that said medicament is a said medicament on any pharmaceutics.
4, the leukemic herbal wine of treatment according to claim 4 is characterized in that said medicament is a medicated wine.
5, the leukemic herbal wine of treatment according to claim 1 and 2, the number of degrees that it is characterized in that said Chinese liquor are 50 to 55 degree.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 98113258 CN1202374A (en) | 1998-06-19 | 1998-06-19 | Chinese herbal medicine wine for curing leukamia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 98113258 CN1202374A (en) | 1998-06-19 | 1998-06-19 | Chinese herbal medicine wine for curing leukamia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1202374A true CN1202374A (en) | 1998-12-23 |
Family
ID=5223011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 98113258 Pending CN1202374A (en) | 1998-06-19 | 1998-06-19 | Chinese herbal medicine wine for curing leukamia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1202374A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103316119A (en) * | 2013-05-17 | 2013-09-25 | 胡庆华 | Traditional Chinese medicine for treating leukemia |
CN104248720A (en) * | 2013-06-29 | 2014-12-31 | 仁怀市克栓益寿酒研究会 | Preparation method for medicinal liquor promoting regeneration function of stem cells |
CN105838541A (en) * | 2016-05-18 | 2016-08-10 | 广西靖西梁鹏食品有限公司 | Preparation method of Chinese herbal medicine wine yeast |
CN107446778A (en) * | 2017-09-07 | 2017-12-08 | 海南正生堂食品科技有限公司 | The immersion extract of beautiful millettia root |
-
1998
- 1998-06-19 CN CN 98113258 patent/CN1202374A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103316119A (en) * | 2013-05-17 | 2013-09-25 | 胡庆华 | Traditional Chinese medicine for treating leukemia |
CN103316119B (en) * | 2013-05-17 | 2014-08-06 | 胡庆华 | Traditional Chinese medicine for treating leukemia |
CN104248720A (en) * | 2013-06-29 | 2014-12-31 | 仁怀市克栓益寿酒研究会 | Preparation method for medicinal liquor promoting regeneration function of stem cells |
CN105838541A (en) * | 2016-05-18 | 2016-08-10 | 广西靖西梁鹏食品有限公司 | Preparation method of Chinese herbal medicine wine yeast |
CN107446778A (en) * | 2017-09-07 | 2017-12-08 | 海南正生堂食品科技有限公司 | The immersion extract of beautiful millettia root |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101874874B (en) | Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof | |
CN102671130A (en) | Anti-tumor traditional Chinese medicine | |
CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
CN100593417C (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
CN102579753A (en) | Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery | |
CN104383495A (en) | Drug for treating neural injury caused by chemotherapy and preparation method of drug | |
CN1202374A (en) | Chinese herbal medicine wine for curing leukamia | |
CN103721196A (en) | Traditional Chinese medicine composition for treating liver cancer | |
CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
CN103977256A (en) | Medicine composition for treating cancer | |
CN103784932A (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
CN104922456A (en) | Traditional Chinese medicine composition for treating anemia after tumor chemotherapy | |
CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
CN104547896A (en) | Anti-tumor traditional Chinese medicine and preparation method thereof | |
CN103751355B (en) | A kind of have the pharmaceutical composition promoting leukocyte effect | |
CN1074292C (en) | Cancer treating medicine capsule | |
CN104173913A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
CN103735635A (en) | Medicinal composition for treating cancers and leukemia | |
CN103566294B (en) | Traditional Chinese medicine composition for removing tumors | |
CN103272123B (en) | Chinese herbal preparation for treating rectum carcinoma and preparation method thereof | |
CN1194717C (en) | Snake poison capsule for treating lung cancer and its preparation method | |
CN105796989A (en) | Traditional Chinese medicine composition for treating leukemia | |
CN104623549A (en) | Traditional Chinese medicine preparation for treating costal chondritis | |
Li | Observations on the Therapeutic Effect of Point-Through-Point Acupuncture Plus Chinese Herbal Medicine on Intractable Hiccup in Tumor Patients. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |